This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Homo sapiens
In vitro/In vivo
In vitro
In vivo
By sample type
Blood
Colorectal cancer cell (SW480)
Leukemia cell (K562)
Liver cancer cells (MHCC-97L)
Lung cancer cell (DMS563)
Lung cancer cell (NCI_H69)
Lung cancer cell (SBC-3)
Mast cell (HMC-1)
Metastatic gastric cacncer cell (AZP7a)
Metastatic gastric cancer cell (AZ521)
Multiple myeloma cells (KMS-11)
Multiple myeloma cells (RPMI8226)
Pancreatic cancer cells (AsPC1, BxPC3, Capan1, Capan2, MiaPaca2, Panc1, Pt45P1, A818, Colo357, HD3577)
Plasma
Serum
By sample status
Colorectal cancer_stage4
Colorectal cancer_stage4_after_resection
Healthy_timepoint1
Multiple sclerosis
Normal
Normal_Exiqon
Pancreatic cancer patient_Agilent
Pancreatic cancer patient_Exiqon
Pollen allergy_timepoint1
Pollen allergy_timepoint2
Sample A_Biooscientific
Sample A_Illumina
Sample B_Biooscientific
Sample B_NEB
Sample C_NEB
Survived under long-term hypoxia
Transplant islets into mouse xenotransplantation
Type 1 diabetes
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-122-5p
MIMAT0000421
0.0e+0
1.7e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
4.6e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
2.7e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
1.7e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
3.0e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
3.6e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
4.8e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
4.0e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
4.6e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
3.6e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
4.2e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
4.9e-1
Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18389. eCollection 2012.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
4.9e-1
Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18389. eCollection 2012.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
4.9e-1
Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18389. eCollection 2012.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
4.8e-1
Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18389. eCollection 2012.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
1.3e-7
0.0e+0
Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells.
J Biol Chem. 2013 Nov 29;288(48):34343-51. doi: 10.1074/jbc.M113.480822. Epub 2013 Oct 16.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
4.8e-1
Circulating exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
5.0e-1
Circulating exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
4.6e-1
Circulating exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
4.1e-1
Circulating exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
4.5e-1
Circulating exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
4.6e-1
Circulating exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
4.7e-1
Circulating exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
4.8e-1
Circulating exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
1.6e-1
The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
3.6e-4
The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
2.9e-2
The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
5.5e-3
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
3.8e-3
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
1.3e-5
4.2e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
2.3e-6
4.1e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
3.1e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
0.0e+0
2.1e-2
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
8.1e-3
4.8e-1
Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
1.5e-2
1.5e-2
Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis.
Nat Commun. 2018 Jan 2;9(1):17. doi: 10.1038/s41467-017-02406-2.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
3.5e-2
3.5e-2
Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis.
Nat Commun. 2018 Jan 2;9(1):17. doi: 10.1038/s41467-017-02406-2.
MIPF0000095_1
47
/
0
/
47
hsa-miR-122-5p
MIMAT0000421
3.2e-3
3.2e-3
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000095_1
47
/
0
/
47
[1]